![Thomas Biancardi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Biancardi
Plus aucun poste en cours
Profil
Thomas Biancardi worked as a Director of Operations Planning & Analysis at Pfizer Inc. and as a Senior Director of Finance & Operations at Oldtech, Inc. He also worked as the Head of Investor Relations and VP of Finance & Operations at IVERIC bio, Inc. from 2013 to 2015.
Biancardi received his undergraduate degree from Rutgers State University of New Jersey and his MBA from New York University.
Anciens postes connus de Thomas Biancardi
Sociétés | Poste | Fin |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | - |
IVERIC BIO, INC. | Directeur des opérations | 31/01/2012 |
Oldtech, Inc.
![]() Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Directeur Financier/CFO | - |
Formation de Thomas Biancardi
New York University | Masters Business Admin |
Rutgers State University of New Jersey | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
Sociétés cotées | 1 |
---|---|
PFIZER, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Oldtech, Inc.
![]() Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
IVERIC bio, Inc.
![]() IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |